Xiaoqiang Fei

Dorzagliatin add-on therapy to metformin in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled phase 3 trial

Wenying Yang, Dalong Zhu, Shenglian Gan et al. · Nature Medicine · 2022 · 73 citations · Full text

Metabolic Syndrome, Adverse Events, Diabetes Management +10

miRNA‑214 suppresses oxidative stress in diabetic nephropathy via the ROS/Akt/mTOR signaling pathway and uncoupling protein 2

Shufang Yang, Xiaoqiang Fei, Lu Yu et al. · Experimental and Therapeutic Medicine · 2019 · 47 citations · Full text

Let‑7a‑5p may participate in the pathogenesis of diabetic nephropathy through targeting HMGA2

Tao Wang, Hua Zhu, Shufang Yang et al. · Molecular Medicine Reports · 2019 · 33 citations · Full text

Immunology, Renal Inflammation, Insulin Signaling +18

SIRT5 regulates pancreatic β‑cell proliferation and insulin secretion in type 2 diabetes

Yongmei Ma, Xiaoqiang Fei · Experimental and Therapeutic Medicine · 2018 · 28 citations · Full text

Small sized gold nanoparticles inhibit the proliferation and invasion of SW579 cells

Qingqing Zhang, Yongmei Ma, Shufang Yang et al. · Molecular Medicine Reports · 2012 · 15 citations · Full text

Nanoparticles, Nanotherapeutics, Engineering +16